Volksgarten, Vienna.

The European Cancer Congress 2015 took place September 25-29 in Vienna, Austria.

Living conditions linked to risk of Hodgkin lymphoma

Crowded street
Photo by Pavel Novak

Living in overcrowded conditions may affect a young person’s risk of developing certain subtypes of Hodgkin lymphoma (HL), according to researchers. They studied more than 600 children and young adults with HL in England and found that patients who lived in areas with more overcrowded households had a... [Read Article]

Group calls for more investment in radiotherapy

Radiation therapist preparing
woman for radiotherapy
Photo by Rhoda Baer

Millions of people throughout the world are dying from potentially treatable cancers because of a chronic underinvestment in radiotherapy resources, according to a new report. The report suggests that expanding access to radiotherapy services will require a sizeable investment upfront, but that investment... [Read Article]

Problems in pediatric cancer care in Europe

Doctor and patient
Photo by Logan Tuttle

Despite progress made in recent years, there are “major problems” in pediatric oncology care in Europe, according to a report from the European Society for Paediatric Oncology (SIOPE). Cancer is still the first cause of death by disease in children age 1 and older in Europe, and... [Read Article]

Pregnant cancer patients: Start treatment ASAP

Pregnant woman
Photo by Nina Matthews

Women who are pregnant when diagnosed with cancer should carry their child to term but start cancer treatment immediately, according to researchers. A study of young children suggested that exposure to cancer treatment in utero did not have detrimental effects on a child’s mental development or heart function.... [Read Article]

Variations in blood cancer survival across Europe

Cancer patient receiving
Photo by Rhoda Baer

Results of the EUROCARE-5 study have revealed regional differences in survival for European patients with hematologic malignancies. The data showed regional variations in 5-year relative survival rates for a number of cancers. But the differences were particularly pronounced for leukemias, non-Hodgkin lymphomas (NHLs), and plasma... [Read Article]